Founded by early pioneers of T cell receptor (TCR) therapy, T-Cure strives to find cure of human cancer using its cutting edge TCR-T technologies.
Using its proprietary iSORT TCR discovery platform, T-Cure expects to rapidly grow its pipeline of therapy candidates. The Company believes its TCR hold great promise in treating patients unaddressed by current modalities.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Sherman Oaks, Ca 91411, Us
- Industry
- Biotechnology
- Website
- t-cure.com
- Keywords
- TCR Therapy, Novel Targets, Immuno-Oncology.
- HQ
- Sherman Oaks, CA
T-Cure Bioscience, Inc Questions
T-Cure Bioscience, Inc's website is t-cure.com
T-Cure Bioscience, Inc's LinkedIn profile is https://www.linkedin.com/company/t-cure-biosciences-inc
T-Cure Bioscience, Inc has
4 employees.
View email and phone details for 4
employees at T-Cure Bioscience, Inc.
T-Cure Bioscience, Inc's industry is
Biotechnology
T-Cure Bioscience, Inc's top competitors are
Neogene Therapeutics,
Immatics,
Alaunos Therapeutics,
Lion Tcr,
Repertoire Immune Medicines,
Bluesphere Bio,
Immunocore,
T-Knife Therapeutics,
Engimmune Therapeutics,
Deverra Therapeutics.
T-Cure Bioscience, Inc's categories are Biotechnology
T-Cure Bioscience, Inc's founding year is 2017
